Study design and subjects
hypertrophic scarring, hypersensitivity, keloids, psoriasis
SKIN CONDITION, HYPERSENSITIVITY, PSORIASIS
A total of 24 healthy male and female Caucasian (Fitzpatrick skin type I–III) volunteers, aged between 18 and 45 years, were enrolled in this study. Health status was confirmed by medical history, physical examination, laboratory tests, and 12-lead electrocardiography (ECG). None of the participants had a family history of psoriasis, no pathological skin conditions at the treatment area, no history of hypertrophic scarring or keloids, no prior use of imiquimod, and no known hypersensitivity to prednisolone.